Cryo-Cell International (CCEL) Stock: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$3.99
-0.06 (-1.48%)
▼
5d:
-5.9%
30d:
-1.24%
90d:
+10.53%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 21, 2026
18d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CCEL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CCEL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $3.99, which is considered oversold relative to its 30-day fair value range of $4.00 to $4.36. The stock's valuation (Forward PE: 199.5) is in line with its historical norms (186.1). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.49, while resistance sits at $4.61.
Market Sentiment: CCEL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+113.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.49, while resistance sits at $4.61.
Market Sentiment: CCEL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+113.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.00 -
$4.36
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.0% below Wall St target ($8.50)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.00 -
$4.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.49
Resistance Level
$4.61
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
199.50
Wall Street Target
$8.50
(+113.0%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
72.1%
Profit Margin
-7.9%
Valuation Premium vs History
+2.4% premium
PE vs Historical
199.5 vs 186.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$4.09
(+2%)
2-Year Target
$4.18
(+5%)
3-Year Target
$4.28
(+7%)
3-Yr Target (if PE normalizes)
(PE: 200→186)
PE COMPRESSION
$4.00
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 199.5, Growth: -81.8%)
$2.91
(+-27%)
Base:
(SPY PE: 20.4, Growth: -81.8%)
$0.30
(-93%)
Bear:
(PE: 17.3, Growth: -81.8%)
$0.25
(-94%)
Share & Embed Analysis
Last updated: October 02, 2026 5:46 PM ET
Data refreshes hourly during market hours. Next update: 6:46 PM
Data refreshes hourly during market hours. Next update: 6:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
